Updates: Company News; Industry trends

Industry trends

The latest review by Chen Zhen team of Tsinghua University: Important progress has been made in microbial synthesis of diols and 3 types of specific biod diols have been commercially produced

Learn more

2024-06-03 19:34:00

06 / 03

2024
Yuan Yingjin team: Through advanced engineering strategies to achieve efficient conversion of lignin to highly homogeneous PHA

Learn more

2024-05-30 19:19:00

05 / 30

2024
Using microbial fermentation to convert CO₂ into fat the Wyss Institute spin-off company has received more than $8 million in financing and its first product is about to hit the market

Learn more

2024-05-16 19:18:00

05 / 16

2024
Jay Keasling's team fully biosynthesizes QS-21 in engineered yeast making it more economical to produce potent adjuvants and reduce vaccine costs

Learn more

2024-05-09 19:18:04

05 / 09

2024
The latest review by Chen Guoqiang's team: Extremophiles are expected to become the "next generation" cell factories that can be used to produce a variety of high-value compounds

Learn more

2024-04-29 19:17:00

04 / 29

2024
With a focus on alternative proteins the Bezos Earth Foundation launched the "AI Climate and Nature" Challenge with $100 million

Learn more

2024-04-28 18:16:00

04 / 28

2024
Motif Neurotech which develops brain-computer interfaces that only need to penetrate the skull has completed human testing and published papers

Learn more

2024-04-21 20:16:00

04 / 21

2024
2024 Top 10 trends in the synthetic biology industry track: Gene therapy is far ahead and alternative proteins have great potential

Learn more

2024-04-02 18:38:00

04 / 02

2024

Industry trends

The latest review by Chen Zhen team of Tsinghua University: Important progress has been made in microbial synthesis of diols and 3 types of specific biod diols have been commercially produced

Yuan Yingjin team: Through advanced engineering strategies to achieve efficient conversion of lignin to highly homogeneous PHA

Using microbial fermentation to convert CO₂ into fat the Wyss Institute spin-off company has received more than $8 million in financing and its first product is about to hit the market

Jay Keasling's team fully biosynthesizes QS-21 in engineered yeast making it more economical to produce potent adjuvants and reduce vaccine costs

The latest review by Chen Guoqiang's team: Extremophiles are expected to become the "next generation" cell factories that can be used to produce a variety of high-value compounds

With a focus on alternative proteins the Bezos Earth Foundation launched the "AI Climate and Nature" Challenge with $100 million

Motif Neurotech which develops brain-computer interfaces that only need to penetrate the skull has completed human testing and published papers

2024 Top 10 trends in the synthetic biology industry track: Gene therapy is far ahead and alternative proteins have great potential